trial
as of 2026-07-01Neuroplasticity in TBI and Schizophrenia
NCTId NCT03995368
at a glance
— · Completed
Enrollment 93 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2023-04-19
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
93 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2020-11-09
Primary completion
2023-04-19
Eligibility
ALL · 25 Years · 55 Years
Interventions & indications
Sponsors
VA Office of Research and DevelopmentLead Sponsor
Investigators
1
Jonathan K Wynn, PhDPrincipal Investigator
Sites
1 total
West Los Angeles, United States
Facts & assertions
4 sourced
Enrollment
93
Phase
NA
Primary Completion Date
2023-04-19
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person